603087 Gan & Lee Pharmaceuticals.
- 44.95
- +2.59+6.11%
Gan & Lee Pharmaceuticals. News
Announcement on the first repurchase of company shares through centralized bidding
Announcement on the shareholding situation of the top ten shareholders and the top ten shareholders with unlimited sale conditions for share repurchases
Announcement and Repurchase Report on the Plan to Repurchase Shares by means of Centralized Bidding
Announcement on holding the 2024 semi-annual results briefing
Articles of Association of Ganli Pharmaceutical Co., Ltd. (August 2024)
Announcement of Resolutions of the 22nd Meeting of the Fourth Board of Directors
Notice on changing registered capital and amending the “Articles of Association”
2024 Semi-Annual Report
2024 Semi-Annual Report Summary
Special Report on the Deposit and Actual Use of Funds Raised for the Semiannual Year of 2024
Announcement of Resolutions of the 21st Meeting of the Fourth Board of Supervisors
Announcement regarding the FDA approval of the clinical trial for pharmaceuticals by our subsidiary in the USA.
Announcement of Resolutions of the Twentieth Meeting of the Fourth Supervisory Board.
CITIC Securities Co., Ltd.'s verification opinion on Gan & Lee Pharmaceuticals Co., Ltd.'s continuing use of idle raised funds for cash management.
Announcement of resolutions of the 21st meeting of the fourth board of directors
Announcement regarding the continued use of idle funds raised for cash management.
Gan & Lee Pharmaceuticals.: Legal Opinion of Zhong Lun Law Firm on the Repurchase and Cancellation of Restricted Stocks under the 2022 Restricted Stock Incentive Plan of Gan & Lee Pharmaceuticals Co., Ltd. in Beijing
Gan & Lee Pharmaceuticals.: Announcement on the implementation of cancellation of part of restricted stock repurchase plan for 2022 restricted stock incentive plan.
Announcement on the "Improve Efficiency and Return to Profit" Action Plan for the Year 2024.
Announcement of expected increase in performance for the first half of 2024.
Analysis
Price Target
No Data
No Data